Interchange Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Buy
+472
New +$265K 0.05% 350
2022
Q2
Sell
-439
Closed -$240K 161
2022
Q1
$240K Buy
439
+62
+16% +$32.6K 0.25% 137
2021
Q4
$248K Buy
+377
New +$237K 0.25% 131
2021
Q2
Sell
-430
Closed -$249K 143
2021
Q1
$249K Sell
430
-82
-16% -$41.1K 0.14% 193
2020
Q4
$255K Buy
+512
New +$229K 0.14% 167

Other funds holding IDXX

Interchange Capital Partners's IDXX Position: Q2 2026 in Review

Interchange Capital Partners opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 472 shares worth $248K. The stake represents 0.05% of the portfolio and ranks #350 among its holdings. This is a return to the name: Interchange Capital Partners previously reported a position in IDXX as recently as Q1 2022.

Interchange Capital Partners first reported a position in IDXX in Q4 2020 and has held it in 5 quarters since. The position peaked at $255K in Q4 2020. 208 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Interchange Capital Partners held 472 shares of Idexx Laboratories worth $248K as of Q2 2026.
  • Idexx Laboratories was a new Interchange Capital Partners position in Q2 2026.
  • Idexx Laboratories made up 0.05% of Interchange Capital Partners's portfolio in Q2 2026, its #350 holding.
  • Interchange Capital Partners first reported a position in Idexx Laboratories in Q4 2020 and has held it in 5 quarters since.
  • Interchange Capital Partners's Idexx Laboratories position peaked at $255K in Q4 2020.
  • 208 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.